Dysregulation of NICD signaling has been implicated in multiple cancers. Overactivation of NICD can lead to uncontrolled cell proliferation and suppression of apoptosis, contributing to oncogenesis. For example, aberrant NICD signaling is observed in T-cell acute lymphoblastic leukemia (T-ALL).
